XML 15 R6.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Statements of Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Balance at Dec. 31, 2023 $ 2,781,974 $ 913 $ 2,649,340 $ 131,721
Balance, Shares at Dec. 31, 2023   91,264,000    
Common stock issued under stock incentive plans 4,102 $ 3 4,099  
Common stock issued under stock incentive plans, shares   310,000    
Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises (5,115)   (5,115)  
Equity-based compensation expense 8,678   8,678  
Net income attributable to Acadia Healthcare Company, Inc. 76,383     76,383
Balance at Mar. 31, 2024 2,866,022 $ 916 2,657,002 208,104
Balance, Shares at Mar. 31, 2024   91,574,000    
Balance at Dec. 31, 2023 2,781,974 $ 913 2,649,340 131,721
Balance, Shares at Dec. 31, 2023   91,264,000    
Net income attributable to Acadia Healthcare Company, Inc. 154,865      
Balance at Jun. 30, 2024 2,952,718 $ 917 2,665,215 286,586
Balance, Shares at Jun. 30, 2024   91,681,000    
Balance at Dec. 31, 2023 $ 2,781,974 $ 913 2,649,340 131,721
Balance, Shares at Dec. 31, 2023   91,264,000    
Common stock issued under stock incentive plans, shares 158,714      
Balance at Dec. 31, 2024 $ 3,073,715 $ 918 2,685,464 387,333
Balance, shares at Dec. 31, 2024 91,775,264      
Balance, Shares at Dec. 31, 2024   91,775,000    
Balance at Mar. 31, 2024 $ 2,866,022 $ 916 2,657,002 208,104
Balance, Shares at Mar. 31, 2024   91,574,000    
Common stock issued under stock incentive plans 1,478 $ 1 1,477  
Common stock issued under stock incentive plans, shares   107,000    
Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises (2,133)   (2,133)  
Equity-based compensation expense 8,869   8,869  
Net income attributable to Acadia Healthcare Company, Inc. 78,482     78,482
Balance at Jun. 30, 2024 2,952,718 $ 917 2,665,215 286,586
Balance, Shares at Jun. 30, 2024   91,681,000    
Common stock issued under stock incentive plans 1,609 $ 1 1,608  
Common stock issued under stock incentive plans, shares   76,000    
Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises (765)   (765)  
Equity-based compensation expense 9,467   9,467  
Other 357   357  
Net income attributable to Acadia Healthcare Company, Inc. 68,132     68,132
Balance at Sep. 30, 2024 3,031,518 $ 918 2,675,882 354,718
Balance, Shares at Sep. 30, 2024   91,757,000    
Common stock issued under stock incentive plans 21   21  
Common stock issued under stock incentive plans, shares   18,000    
Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises (538)   (538)  
Equity-based compensation expense 10,099   10,099  
Net income attributable to Acadia Healthcare Company, Inc. 32,615     32,615
Balance at Dec. 31, 2024 $ 3,073,715 $ 918 2,685,464 387,333
Balance, shares at Dec. 31, 2024 91,775,264      
Balance, Shares at Dec. 31, 2024   91,775,000    
Common stock issued under stock incentive plans   $ 2 (2)  
Common stock issued under stock incentive plans, shares   217,000    
Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises $ (1,936)   (1,936)  
Repurchase of common stock (47,272) $ (16)   (47,256)
Repurchase of common stock, shares   (1,603,000)    
Equity-based compensation expense 8,677   8,677  
Net income attributable to Acadia Healthcare Company, Inc. 8,374     8,374
Balance at Mar. 31, 2025 3,041,558 $ 904 2,692,203 348,451
Balance, Shares at Mar. 31, 2025   90,389,000    
Balance at Dec. 31, 2024 $ 3,073,715 $ 918 2,685,464 387,333
Balance, shares at Dec. 31, 2024 91,775,264      
Balance, Shares at Dec. 31, 2024   91,775,000    
Repurchase of common stock $ (50,400)      
Net income attributable to Acadia Healthcare Company, Inc. 38,501      
Balance at Jun. 30, 2025 $ 3,077,986 $ 904 2,701,663 375,419
Balance, shares at Jun. 30, 2025 90,393,824      
Balance, Shares at Jun. 30, 2025   90,394,000    
Balance at Mar. 31, 2025 $ 3,041,558 $ 904 2,692,203 348,451
Balance, Shares at Mar. 31, 2025   90,389,000    
Common stock issued under stock incentive plans   $ 1 (1)  
Common stock issued under stock incentive plans, shares   109,000    
Repurchase of shares for payroll tax withholding, net of proceeds from stock option exercises (1,780)   (1,780)  
Repurchase of common stock (3,160) $ (1)   (3,159)
Repurchase of common stock, shares   (104,000)    
Equity-based compensation expense 10,549   10,549  
Other 692   692  
Net income attributable to Acadia Healthcare Company, Inc. 30,127     30,127
Balance at Jun. 30, 2025 $ 3,077,986 $ 904 $ 2,701,663 $ 375,419
Balance, shares at Jun. 30, 2025 90,393,824      
Balance, Shares at Jun. 30, 2025   90,394,000